Compartir
Título
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016-2022)
Autor(es)
Palabras clave
ANCA-associated vasculitis; Eosinophilic granulomatosis with polyangiitis; Epidemiology; Granulomatosis with polyangiitis; Microscopic polyangiitis; Mortality
ANCA-associated vasculitis
Eosinophilic granulomatosis with polyangiitis
Epidemiology
Granulomatosis with polyangiitis
Microscopic polyangiitis
Mortality
Fecha de publicación
2025-08-29
Editor
ELSEVIER
Citación
Cordero-Pérez, F.-J., Martínez-Rodríguez, P., Arribas-Pérez, L., Puertas-Miranda, D., Pires-Baltazar, C.-R., Salcedo-Martín, L., Sánchez-Villoria, J. A., Díaz-Ávila, E. G., Ternavasio-De La Vega, H.-G., Marcos, M., & Chamorro, A.-J. (2025). [Rev. of Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain’s National Health Data (2016–2022)]. Autoimmunity Reviews, 24(9). https://doi.org/10.1016/J.AUTREV.2025.103863
Resumen
[EN]ANCA-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), is a systemic autoimmune disease. This study represents the first large-scale analysis of AAV hospitalisation rates and in-hospital mortality trends in Spain.
A retrospective longitudinal analysis of AAV-related hospital admissions between 2016 and 2022 was conducted using the ICD-10 codes from the Minimum Basic Dataset (MBDS) of the Spanish National Health System. Statistical analyses were performed, including odds ratios, Student's t-tests, and Mantel-Haenszel trend tests.
Among 5753 AAV episodes, GPA was the most frequent subtype (53.9 %), followed by MPA (31.5 %) and EGPA (14.6 %). AAV episodes were more frequent in older patients (> 65 years) than in other hospital episodes (62.9 % vs. 38.9 %; OR: 2.66, 95 %CI: 2.51-2.80; P < 0.001). Larger hospitals accounted for more AAV episodes, longer hospital stays, and higher costs. MPA had the highest mortality rate (7.2 % vs. 4.9 %; OR: 1.52, 95 % CI: 1.27-1.79; P < 0.001), particularly in patients over 65 years (83.1 % vs. 61.8 %; OR: 3.04, 95 % CI: 2.47-3.75; P < 0.001) compared with the other AAV. In the GPA group, renal involvement significantly increased mortality compared to GPA cases without renal involvement (6.6 % vs. 4.6 %; OR: 1.46, 95 % CI: 1.16-1.83; P = 0.011). Notably, the relative risk of AAV-related deaths increased over the study period (Z = 2.77, P < 0.01).
AAV, particularly MPA, is associated with increased hospital mortality, particularly among older adults and patients with renal involvement.
URI
ISSN
1568-9972
DOI
10.1016/j.autrev.2025.103863
Versión del editor
Aparece en las colecciones













